Professor Bronwyn Kingwell’s fundamental and clinical research in arterial biomechanics has driven new approaches for the management of arterial diseases. She has pioneered the transition of detailed cellular and molecular studies of high-density lipoprotein (HDL) in laboratory models, in particular with regard to glucose metabolism, to a human context. This work has opened major new avenues in HDL therapeutics for treatment of diabetes. Her contributions have also influenced national and international physical activity guidelines. Professor Kingwell has been a leader in defining Australian science policy and is an active mentor.

Although for several decades Professor Kilpatrick contributed to improving health outcomes through clinical practice and research, her key contribution and of relevance to Fellowship of the Academy has been her leadership roles in which she has ensured a strong and sustainable integration between medical research and health care delivery. This has been achieved through articulating a clear vision, relationship building and creating opportunities for integration. As CEO Royal Children’s Hospital, she has taken a lead role in establishing the Melbourne Children’s the partnership between RCH, University of Melbourne and Murdoch Children’s Research Institute, to ensure research is embedded in healthcare delivery.

Professor Kaye is an internationally recognised clinician-scientist working who has made a major contribution to the understanding and treatment of heart failure. Prof Kaye is an NHMRC Senior Principal Research Fellow at Baker IDI and an active senior Cardiologist in the Heart Failure- Transplant Unit at the Alfred Hospital, Melbourne. Professor Kaye holds numerous research grants including an NHMRC Program Grant, NHMRC Centre of Research Excellence Grant and an NHMRC Development Grant, with cumulative competitive grant support in excess of $44M. Prof Kaye’s translational research has also created a substantial portfolio of intellectual property that has led to the invention of novel medical devices and pharmacological therapies, including 2 spin-out companies that have raised >$100M.

Professor Stephen Jane is Head of Central Clinical School, Professor of Medicine, Monash University, Director of Research, Alfred Health and Acting Head of Clinical Haematology and The Australian Centre for Blood Diseases. He was previously a Principal Research Fellow of the NHMRC, Professor of Medicine, University of Melbourne and Director of the Bone Marrow Research Laboratories, Royal Melbourne Hospital. His research interests centre on transcriptional regulation in blood and skin, and he currently holds six NH&MRC grants and international competitive funding. He has published over 100 papers including articles in Science, Nature Medicine, Cancer Cell and Developmental Cell.